| 1 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 9.17957313 |
| 2 | regulation of mitochondrial translation (GO:0070129) | 8.54707914 |
| 3 | water-soluble vitamin biosynthetic process (GO:0042364) | 8.41324377 |
| 4 | negative regulation of membrane potential (GO:0045837) | 7.98171242 |
| 5 | pyrimidine nucleotide catabolic process (GO:0006244) | 7.88173185 |
| 6 | base-excision repair, AP site formation (GO:0006285) | 7.42049944 |
| 7 | protein K48-linked deubiquitination (GO:0071108) | 6.94681036 |
| 8 | protein complex biogenesis (GO:0070271) | 6.66057213 |
| 9 | histone deubiquitination (GO:0016578) | 6.52832343 |
| 10 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.46586171 |
| 11 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 6.24515647 |
| 12 | mitochondrial respiratory chain complex assembly (GO:0033108) | 6.00946671 |
| 13 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 5.57031552 |
| 14 | pseudouridine synthesis (GO:0001522) | 5.52278230 |
| 15 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 5.44284750 |
| 16 | cytochrome complex assembly (GO:0017004) | 5.27289545 |
| 17 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 5.19296856 |
| 18 | aggressive behavior (GO:0002118) | 5.17228645 |
| 19 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 4.98298741 |
| 20 | deoxyribonucleotide catabolic process (GO:0009264) | 4.94276015 |
| 21 | cobalamin metabolic process (GO:0009235) | 4.93293140 |
| 22 | protein import into peroxisome matrix (GO:0016558) | 4.67975159 |
| 23 | deoxyribose phosphate catabolic process (GO:0046386) | 4.67313418 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.57643063 |
| 25 | regulation of endothelial cell differentiation (GO:0045601) | 4.55882082 |
| 26 | maternal behavior (GO:0042711) | 4.50679526 |
| 27 | response to gravity (GO:0009629) | 4.49065282 |
| 28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.20549693 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 4.20549693 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.20549693 |
| 31 | embryonic skeletal joint morphogenesis (GO:0060272) | 4.13521106 |
| 32 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.12843325 |
| 33 | vitamin biosynthetic process (GO:0009110) | 4.11751490 |
| 34 | parental behavior (GO:0060746) | 3.93373760 |
| 35 | glyoxylate metabolic process (GO:0046487) | 3.89893713 |
| 36 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.74733731 |
| 37 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.74733731 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 3.70976163 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.70976163 |
| 40 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.70237754 |
| 41 | positive regulation of fatty acid transport (GO:2000193) | 3.65457111 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.64019605 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.64019605 |
| 44 | energy homeostasis (GO:0097009) | 3.56100442 |
| 45 | middle ear morphogenesis (GO:0042474) | 3.53519152 |
| 46 | angiogenesis involved in wound healing (GO:0060055) | 3.47644447 |
| 47 | long term synaptic depression (GO:0060292) | 3.46340047 |
| 48 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.41950815 |
| 49 | protein neddylation (GO:0045116) | 3.40118414 |
| 50 | proteasome assembly (GO:0043248) | 3.34681791 |
| 51 | kidney mesenchyme development (GO:0072074) | 3.30951592 |
| 52 | chaperone-mediated protein transport (GO:0072321) | 3.29922945 |
| 53 | peptidyl-histidine modification (GO:0018202) | 3.28054121 |
| 54 | behavioral response to nicotine (GO:0035095) | 3.27578781 |
| 55 | protein localization to peroxisome (GO:0072662) | 3.26567312 |
| 56 | protein targeting to peroxisome (GO:0006625) | 3.26567312 |
| 57 | establishment of protein localization to peroxisome (GO:0072663) | 3.26567312 |
| 58 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.26263753 |
| 59 | adaptation of signaling pathway (GO:0023058) | 3.26027640 |
| 60 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.24592924 |
| 61 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.24592924 |
| 62 | serotonin metabolic process (GO:0042428) | 3.23992346 |
| 63 | tetrapyrrole biosynthetic process (GO:0033014) | 3.23194989 |
| 64 | dentate gyrus development (GO:0021542) | 3.20350033 |
| 65 | retinal rod cell development (GO:0046548) | 3.11679597 |
| 66 | cellular response to BMP stimulus (GO:0071773) | 3.09209538 |
| 67 | response to BMP (GO:0071772) | 3.09209538 |
| 68 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.03561906 |
| 69 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.03561906 |
| 70 | deoxyribose phosphate metabolic process (GO:0019692) | 3.02176154 |
| 71 | limb development (GO:0060173) | 3.00957283 |
| 72 | appendage development (GO:0048736) | 3.00957283 |
| 73 | regulation of cardioblast proliferation (GO:0003264) | 3.00068173 |
| 74 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.00068173 |
| 75 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.99313805 |
| 76 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.97699937 |
| 77 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.95842189 |
| 78 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.95842189 |
| 79 | negative regulation of appetite (GO:0032099) | 2.93077527 |
| 80 | negative regulation of response to food (GO:0032096) | 2.93077527 |
| 81 | positive regulation of TOR signaling (GO:0032008) | 2.90499196 |
| 82 | negative regulation of phagocytosis (GO:0050765) | 2.89310634 |
| 83 | negative regulation of cell aging (GO:0090344) | 2.88584887 |
| 84 | response to misfolded protein (GO:0051788) | 2.88062907 |
| 85 | deoxyribonucleotide metabolic process (GO:0009262) | 2.86643578 |
| 86 | forebrain morphogenesis (GO:0048853) | 2.86607944 |
| 87 | peroxisomal transport (GO:0043574) | 2.83776772 |
| 88 | activin receptor signaling pathway (GO:0032924) | 2.82878743 |
| 89 | behavioral response to cocaine (GO:0048148) | 2.78965704 |
| 90 | primary amino compound metabolic process (GO:1901160) | 2.78865416 |
| 91 | synaptic transmission, dopaminergic (GO:0001963) | 2.77559348 |
| 92 | regulation of neurotransmitter uptake (GO:0051580) | 2.76696745 |
| 93 | adenosine metabolic process (GO:0046085) | 2.76123117 |
| 94 | DNA catabolic process, endonucleolytic (GO:0000737) | 2.74120300 |
| 95 | actin filament polymerization (GO:0030041) | 2.73818688 |
| 96 | intracellular protein transmembrane import (GO:0044743) | 2.73245876 |
| 97 | metanephric mesenchyme development (GO:0072075) | 2.73149108 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 2.69720956 |
| 99 | replication fork processing (GO:0031297) | 2.66940646 |
| 100 | monoubiquitinated protein deubiquitination (GO:0035520) | 14.0796829 |
FAM86KP 
